China Biopharmaceutical Third Party Logistics (3PL) Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Biopharmaceutical Third Party Logistics (3PL) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • DHL International GmbH

    • Agility

    • Kerry logistics Network Limited

    • United Parcel Service of America, Inc

    • AmerisourceBergen Corporation

    • Kuehne and Nagel

    • DB Schenker

    By Type:

    • Non-cold Chain

    • Cold Chain

    By Application:

    • Warehousing and Storage

    • Others

    • Transportation

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Biopharmaceutical Third Party Logistics (3PL) Market Overview 2018-2029

    • 1.1 China Biopharmaceutical Third Party Logistics (3PL) Industry Development Overview

    • 1.2 China Biopharmaceutical Third Party Logistics (3PL) Industry Development History

    • 1.3 China Biopharmaceutical Third Party Logistics (3PL) Industry Market Size (2018-2029)

    • 1.4 China Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Type from Production Side

      • 1.4.1 China Biopharmaceutical Third Party Logistics (3PL) Production Volume, Production Value and Growth Rate of Non-cold Chain (2018-2029)

      • 1.4.2 China Biopharmaceutical Third Party Logistics (3PL) Production Volume, Production Value and Growth Rate of Cold Chain (2018-2029)

    • 1.5 China Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Application from Consumption End

      • 1.5.1 China Biopharmaceutical Third Party Logistics (3PL) Sales Volume, Sales Value and Growth Rate of Warehousing and Storage (2018-2029)

      • 1.5.2 China Biopharmaceutical Third Party Logistics (3PL) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Biopharmaceutical Third Party Logistics (3PL) Sales Volume, Sales Value and Growth Rate of Transportation (2018-2029)

    • 1.6 China Biopharmaceutical Third Party Logistics (3PL) Market Analysis by Region

      • 1.6.1 North China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Biopharmaceutical Third Party Logistics (3PL) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Biopharmaceutical Third Party Logistics (3PL) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Biopharmaceutical Third Party Logistics (3PL) Market Status and Competition Analysis in 2023

      • 2.2.3 China Biopharmaceutical Third Party Logistics (3PL) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Biopharmaceutical Third Party Logistics (3PL) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Biopharmaceutical Third Party Logistics (3PL) Industry Development

    Chapter 3 Biopharmaceutical Third Party Logistics (3PL)Industry Chain Analysis

    • 3.1 Biopharmaceutical Third Party Logistics (3PL) Industry Chain

    • 3.2 Biopharmaceutical Third Party Logistics (3PL) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Biopharmaceutical Third Party Logistics (3PL) Market

    • 3.3 Biopharmaceutical Third Party Logistics (3PL) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Biopharmaceutical Third Party Logistics (3PL) Market

    Chapter 4 China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 4.1 China Biopharmaceutical Third Party Logistics (3PL) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Biopharmaceutical Third Party Logistics (3PL) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Biopharmaceutical Third Party Logistics (3PL) Production Volume and Growth Rate, by Type

      • 4.5.1 China Biopharmaceutical Third Party Logistics (3PL) Production Volume and Growth Rate of Non-cold Chain

      • 4.5.2 China Biopharmaceutical Third Party Logistics (3PL) Production Volume and Growth Rate of Cold Chain

    Chapter 5 China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Biopharmaceutical Third Party Logistics (3PL) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate, by Application

      • 5.5.1 China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate of Warehousing and Storage

      • 5.5.2 China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate of Others

      • 5.5.3 China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate of Transportation

    Chapter 6 China Biopharmaceutical Third Party Logistics (3PL) Market, by Region

    • 6.1 China Biopharmaceutical Third Party Logistics (3PL) Production Volume and Production Value, by Region

    • 6.2 China Biopharmaceutical Third Party Logistics (3PL) Sales Volume and Sales Value, by Region

    Chapter 7 North China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 7.1 North China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 7.2 North China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 8 Central China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 8.1 Central China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 8.2 Central China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 9 South China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 9.1 South China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 9.2 South China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 10 East China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 10.1 East China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 10.2 East China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 11 Northeast China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 11.1 Northeast China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 11.2 Northeast China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 12 Southwest China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 12.1 Southwest China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 12.2 Southwest China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 13 Northwest China Biopharmaceutical Third Party Logistics (3PL) Market Analysis

    • 13.1 Northwest China Biopharmaceutical Third Party Logistics (3PL) Market, by Type

    • 13.2 Northwest China Biopharmaceutical Third Party Logistics (3PL) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 DHL International GmbH

        • 14.1.1 DHL International GmbH Company Profile

        • 14.1.2 DHL International GmbH Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Agility

        • 14.2.1 Agility Company Profile

        • 14.2.2 Agility Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Kerry logistics Network Limited

        • 14.3.1 Kerry logistics Network Limited Company Profile

        • 14.3.2 Kerry logistics Network Limited Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 United Parcel Service of America, Inc

        • 14.4.1 United Parcel Service of America, Inc Company Profile

        • 14.4.2 United Parcel Service of America, Inc Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 AmerisourceBergen Corporation

        • 14.5.1 AmerisourceBergen Corporation Company Profile

        • 14.5.2 AmerisourceBergen Corporation Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Kuehne and Nagel

        • 14.6.1 Kuehne and Nagel Company Profile

        • 14.6.2 Kuehne and Nagel Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 DB Schenker

        • 14.7.1 DB Schenker Company Profile

        • 14.7.2 DB Schenker Biopharmaceutical Third Party Logistics (3PL) Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Biopharmaceutical Third Party Logistics (3PL) Industry Research Conclusions

    • 15.2 Biopharmaceutical Third Party Logistics (3PL) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Industry Market Size (2018-2029)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Production Volume, Production Value and Growth Rate of Non-cold Chain (2018-2029)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Production Volume, Production Value and Growth Rate of Cold Chain (2018-2029)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Sales Volume, Sales Value and Growth Rate of Warehousing and Storage (2018-2029)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Sales Volume, Sales Value and Growth Rate of Transportation (2018-2029)

    • Figure North China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure Central China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure South China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure East China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate from 2018-2029

    • Figure Biopharmaceutical Third Party Logistics (3PL) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Share by Type in 2018

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Share by Type in 2023

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Production Volume and Growth Rate of Non-cold Chain (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Production Volume and Growth Rate of Cold Chain (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Share by Application in 2018

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Share by Application in 2023

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Total Market Size and Growth Rate from Consumption End

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate of Warehousing and Storage (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Market Size and Growth Rate of Transportation (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Region (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Production Value by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Production Value Share by Region (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Production Value Share by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Region (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Sales Value by Region (2018-2023)

    • Table China Biopharmaceutical Third Party Logistics (3PL) Sales Value Share by Region (2018-2023)

    • Figure China Biopharmaceutical Third Party Logistics (3PL) Sales Value Share by Region (2018-2023)

    • Table North China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table North China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure North China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table North China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table North China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure North China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table Central China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table Central China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure Central China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table Central China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table Central China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure Central China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table South China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table South China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure South China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table South China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table South China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure South China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table East China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table East China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure East China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table East China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table East China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure East China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table Northeast China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table Northeast China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table Northeast China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table Southwest China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table Southwest China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table Southwest China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Biopharmaceutical Third Party Logistics (3PL) Production Volume by Type (2018-2023)

    • Table Northwest China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Biopharmaceutical Third Party Logistics (3PL) Production Volume Share by Type (2018-2023)

    • Table Northwest China Biopharmaceutical Third Party Logistics (3PL) Sales Volume by Application (2018-2023)

    • Table Northwest China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Biopharmaceutical Third Party Logistics (3PL) Sales Volume Share by Application (2018-2023)

    • Table DHL International GmbH Company Profile

    • Table DHL International GmbH Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)

    • Table Agility Company Profile

    • Table Agility Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)

    • Table Kerry logistics Network Limited Company Profile

    • Table Kerry logistics Network Limited Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)

    • Table United Parcel Service of America, Inc Company Profile

    • Table United Parcel Service of America, Inc Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)

    • Table AmerisourceBergen Corporation Company Profile

    • Table AmerisourceBergen Corporation Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)

    • Table Kuehne and Nagel Company Profile

    • Table Kuehne and Nagel Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)

    • Table DB Schenker Company Profile

    • Table DB Schenker Biopharmaceutical Third Party Logistics (3PL) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.